Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$3.02 - $4.05 $2,038 - $2,733
675 Added 50.0%
2,025 $28.5 Million
Q2 2023

Aug 17, 2023

BUY
$2.79 - $5.03 $3,766 - $6,790
1,350 New
1,350 $20.8 Million
Q1 2023

May 19, 2023

SELL
$3.14 - $8.22 $2,119 - $5,548
-675 Closed
0 $0
Q4 2022

May 19, 2023

BUY
$5.77 - $8.49 $3,894 - $5,730
675 New
675 $9.51 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $28.5M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Coppell Advisory Solutions LLC Portfolio

Follow Coppell Advisory Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions LLC with notifications on news.